Browse Drug Recalls
71 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 71 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 71 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jul 17, 2023 | fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL sy... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 1000 mcg/100 mL, (10 mcg/mL), 100 mL bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total V... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% Sodium Chloride, 50 mg/50 mL (1mg/mL), 50 mL Syringe, Rx onl... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% sodium chloride, 1 mg/1 mL, (1 mg/mL), 3 mL Syringe, Rx only... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc.... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syri... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone added to 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 100 mL... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixtur... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixt... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Ce... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 5000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% sodium chloride, 125 mg/25 mL, (5 mg/mL), 30 mL Syringe, Rx ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syring... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.